SCHEMBL19863103

SCHEMBL19863103

c1ccc(-c2ccc(-n3c4c(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)cc5c6ccccc6oc5c4c4ccc5ccccc5c43)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
KDM4E B2RXH2 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 3/20 0.32
TSHR P16473 3/20 0.32
HSD17B10 Q99714 3/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
BRCA1 P38398 1/20 0.32
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
ALOX15 P16050 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HDAC4 P56524 1/20 0.31
CYP1A1 P04798 3/20 0.31
CYP1A2 P05177 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18593659 0.95 SIRT2 (0.35) SIRT2SIRT1KDM4EL3MBTL1ATM
SCHEMBL19863102 0.94 SIRT2 (0.34) SIRT2SIRT1KDM4EL3MBTL1ATM
SCHEMBL19863106 0.90 SIRT2 (0.34) SIRT2SIRT1KDM4EL3MBTL1ATM
SCHEMBL19863159 0.88 KDM4E (0.39) KDM4EL3MBTL1ATMALDH1A1TSHR
SCHEMBL19863107 0.88 SIRT2 (0.34) SIRT2SIRT1KDM4EL3MBTL1ATM
SCHEMBL18593661 0.88 SIRT2 (0.33) SIRT2SIRT1KDM4EALDH1A1TSHR
SCHEMBL18594426 0.88 SIRT2 (0.34) SIRT2SIRT1KDM4EL3MBTL1ATM
SCHEMBL19863113 0.88 ALDH1A1 (0.33) SIRT2SIRT1KDM4EL3MBTL1ALDH1A1
SCHEMBL19863104 0.85 SIRT2 (0.34) SIRT2SIRT1KDM4EL3MBTL1ATM
SCHEMBL19863108 0.85 SIRT2 (0.33) SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 SIRT2 1306/4885SIRT1 1838/4885KDM4E 1039/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 SIRT2 1306/4885SIRT1 1838/4885KDM4E 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.